Ellie Harvie

Recent publications · Crossref

5 total works indexed

1. Pembrolizumab versus docetaxel for previously treated, PD-L1-positive, advanced non-small-cell lung cancer (KEYNOTE-010): a randomised controlled trial

   · 2016 · cited 5,303x

2. Trastuzumab Emtansine for HER2-Positive Advanced Breast Cancer

   · 2012 · cited 3,247x

3. Pembrolizumab alone or with chemotherapy versus cetuximab with chemotherapy for recurrent or metastatic squamous cell carcinoma of the head and neck (KEYNOTE-048): a randomised, open-label, phase 3 study

   · 2019 · cited 2,830x

4. Kidney Disease as a Risk Factor for Development of Cardiovascular Disease

   · 2003 · cited 2,705x

5. Body-mass index and all-cause mortality: individual-participant-data meta-analysis of 239 prospective studies in four continents

   · 2016 · cited 2,242x

via Crossref · CC0

Wikidata facts